Indivior (INDV) Competitors

Viking Therapeutics (NASDAQ:VKTX) and Indivior (NASDAQ:INDV) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

Which has higher earnings and valuation, VKTX or INDV?

Indivior has higher revenue and earnings than Viking Therapeutics. Indivior is trading at a lower price-to-earnings ratio than Viking Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viking Therapeutics	N/A	N/A	-$85.89M	-$0.93	-55.41
Indivior	$1.18B	1.23	$2M	-$0.04	-264.50

Which has more volatility & risk, VKTX or INDV?

Viking Therapeutics has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, Indivior has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500.

Do analysts rate VKTX or INDV?

Viking Therapeutics presently has a consensus price target of $109.80, suggesting a potential upside of 113.08%. Indivior has a consensus price target of $16.00, suggesting a potential upside of 51.23%. Given Viking Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Viking Therapeutics is more favorable than Indivior.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viking Therapeutics	0 Sell rating(s)	0 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	3.09
Indivior	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is VKTX or INDV more profitable?

Viking Therapeutics has a net margin of 0.00% compared to Indivior's net margin of -0.17%. Viking Therapeutics' return on equity of -12.73% beat Indivior's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viking Therapeutics	N/A	-12.73%	-12.31%
Indivior	-0.17%	-351.08%	15.24%

Do insiders & institutionals have more ownership in VKTX or INDV?

76.0% of Viking Therapeutics shares are held by institutional investors. Comparatively, 60.3% of Indivior shares are held by institutional investors. 4.7% of Viking Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Does the media favor VKTX or INDV?

In the previous week, Viking Therapeutics had 21 more articles in the media than Indivior. MarketBeat recorded 24 mentions for Viking Therapeutics and 3 mentions for Indivior. Viking Therapeutics' average media sentiment score of 0.48 beat Indivior's score of 0.00 indicating that Viking Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viking Therapeutics	8 Very Positive mention(s)	4 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Indivior	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community favor VKTX or INDV?

Viking Therapeutics received 606 more outperform votes than Indivior when rated by MarketBeat users. However, 100.00% of users gave Indivior an outperform vote while only 79.74% of users gave Viking Therapeutics an outperform vote.

Company	Underperform	Outperform
Viking Therapeutics	Outperform Votes 614 79.74%	Underperform Votes 156 20.26%
Indivior	Outperform Votes 8 100.00%	Underperform Votes No Votes

Summary

Viking Therapeutics beats Indivior on 13 of the 18 factors compared between the two stocks.